Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.58% higher to $69.36 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.02% to 32,661.84 and the S&P 500 Index falling 0.47% to 3,951.39. The stock's rise snapped a three-day losing streak. Bristol Myers Squibb Co. closed $12.08 short of its 52-week high ($81.44), which the company achieved on December 1st.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) fell 0.45% to $152.57, Pfizer Inc. (PFE) fell 0.96% to $40.18, and Abbott Laboratories (ABT) fell 0.87% to $100.83. Trading volume (5.9 M) remained 2.5 million below its 50-day average volume of 8.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 1, 2023.
(END) Dow Jones Newswires
March 01, 2023 16:42 ET (21:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.